2006
DOI: 10.1111/j.1365-2109.2006.01470.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of dietary echium oil on growth, fatty acid composition and metabolism, gill prostaglandin production and macrophage activity in Atlantic cod (Gadus morhua L.)

Abstract: Echium oil (EO) is a vegetable oil in which percentages of stearidonic acid (STA,18:4n-3) often exceed those of its n-6 series equivalent γ-linolenic acid (GLA, 18:3n-6). STA is elongated to 20:4n-3 in fish cell cultures, suggesting that EO could be included in diets for marine fish to increase tissue 20:4n-3 and 20:3n-6 and, thereby, modulate eicosanoid metabolism. Thus, the present study aimed to test the hypotheses that dietary EO would increase tissue 20:4n-3 and 20:3n-6 and modulate immune function and ei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

12
59
1
5

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 94 publications
(77 citation statements)
references
References 52 publications
12
59
1
5
Order By: Relevance
“…Therefore, studies in marine fish should focus on the use of blends of VOs to obtain a balanced fatty acid profile such as that present in EO to avoid excessive tissue fat deposition. In the same way, the lipid class profile of gilthead seabream enterocytes and hepatocytes was unaffected by EO as reported for other balanced VOs including EO in liver (Mourente et al, 2005;Bell et al, 2006), enterocytes and muscle Miller et al, 2007Miller et al, , 2008, of different fish species.…”
Section: Discussionsupporting
confidence: 72%
See 3 more Smart Citations
“…Therefore, studies in marine fish should focus on the use of blends of VOs to obtain a balanced fatty acid profile such as that present in EO to avoid excessive tissue fat deposition. In the same way, the lipid class profile of gilthead seabream enterocytes and hepatocytes was unaffected by EO as reported for other balanced VOs including EO in liver (Mourente et al, 2005;Bell et al, 2006), enterocytes and muscle Miller et al, 2007Miller et al, , 2008, of different fish species.…”
Section: Discussionsupporting
confidence: 72%
“…There was also a trend for DHA and EPA to decrease but not in a significant way. In many other trials, fish fed VOs displayed significant reductions in n-3HUFA together with increased C 18 fatty acids in liver (Rodríguez et al, 2002;Menoyo et al, 2004;Mourente et al, 2005;Bell et al, 2006;Almaida-Pagán et al, 2007) and enterocytes Mourente et al, 2005;Almaida-Pagán et al, 2007) of different marine fish. Nevertheless, in seabass fed a balanced blend of VOs, enterocytes were capable at regulating fatty acid levels, with C 18 fatty acids not increasing greatly, and EPA and DHA levels relatively maintained (Mourente et al, 2005).…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…In the present study, CLA had no effect on PUFA levels in either liver or flesh of cod. This was perhaps not unexpected as the activity of the PUFA desaturation/elongation pathway is very low in cod (Bell et al, 2006). In contrast, however, dietary TTA significantly increased the percentage of DHA, and decreased the proportions of EPA and total n-6PUFA in flesh of cod.…”
Section: Discussionmentioning
confidence: 86%